Form 8-K NexImmune, Inc. For: Feb 02

Go back to Form 8-K NexImmune, Inc. For: Feb 02

NexImmune (NEXI) Terminates ATM Offering Program

February 2, 2024 1:29 PM EST

As previously disclosed in June 2022, NexImmune (NASDAQ: NEXI) entered into a Controlled Equity Offering SM Sales Agreement (the Sales Agreement) with Cantor Fitzgerald & Co. and BTIG, LLC (together, the Agents), pursuant to which the Company could offer and sell shares of its common stock, par value $0.0001... More